SecSonar.com

Viatris Inc. (VTRS)

Viatris Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Viatris Inc. (VTRS) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $18.8B. Revenue declined 3.0% year-over-year and the company generated $1.9B in free cash flow. This page tracks VTRS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 32K employees · IPO Mar 17, 1980

Valuation

Valuation & price

$16.48 · as of May 17, 2026 · -5.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.28

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$17.26$13.00$8.74Jul 25Dec 25Jul 26Jul 7, 25$9.20Jul 9, 25$9.23Jul 11, 25$9.12Jul 15, 25$8.93Jul 17, 25$9.27Jul 21, 25$8.90Jul 23, 25$9.37Jul 25, 25$9.41Jul 29, 25$9.19Jul 31, 25$8.74Aug 4, 25$8.94Aug 6, 25$8.75Aug 11, 25$9.86Aug 13, 25$10.41Aug 15, 25$10.61Aug 19, 25$10.68Aug 21, 25$10.69Aug 25, 25$10.55Aug 27, 25$10.42Aug 29, 25$10.55Sep 3, 25$10.55Sep 5, 25$10.50Sep 9, 25$10.45Sep 11, 25$10.17Sep 16, 25$9.56Sep 18, 25$9.86Sep 22, 25$9.79Sep 24, 25$9.71Sep 26, 25$9.52Sep 30, 25$9.90Oct 2, 25$10.11Oct 6, 25$10.13Oct 8, 25$9.97Oct 10, 25$9.74Oct 14, 25$9.93Oct 16, 25$10.10Oct 21, 25$10.39Oct 23, 25$10.31Oct 27, 25$10.42Oct 29, 25$10.27Oct 31, 25$10.36Nov 4, 25$10.49Nov 6, 25$10.11Nov 10, 25$10.17Nov 12, 25$11.01Nov 14, 25$10.72Nov 18, 25$10.71Nov 20, 25$10.19Nov 25, 25$10.56Nov 28, 25$10.69Dec 2, 25$10.71Dec 4, 25$10.76Dec 8, 25$11.09Dec 10, 25$11.60Dec 12, 25$11.65Dec 16, 25$11.46Dec 18, 25$11.94Dec 22, 25$12.01Dec 24, 25$12.24Dec 29, 25$12.37Jan 2, 26$12.46Jan 6, 26$12.40Jan 8, 26$12.60Jan 12, 26$12.68Jan 14, 26$13.15Jan 16, 26$12.86Jan 21, 26$13.05Jan 23, 26$13.21Jan 27, 26$13.12Jan 29, 26$13.07Feb 2, 26$13.68Feb 4, 26$14.36Feb 9, 26$15.56Feb 11, 26$16.13Feb 13, 26$15.77Feb 18, 26$16.05Feb 20, 26$15.92Feb 24, 26$16.07Feb 26, 26$15.25Mar 2, 26$15.70Mar 4, 26$14.71Mar 6, 26$14.16Mar 10, 26$14.08Mar 12, 26$13.80Mar 17, 26$13.80Mar 19, 26$13.50Mar 23, 26$13.29Mar 25, 26$13.50Mar 27, 26$13.05Mar 31, 26$13.51Apr 2, 26$13.44Apr 7, 26$13.16Apr 9, 26$13.61Apr 13, 26$13.83Apr 15, 26$13.86Apr 17, 26$14.68Apr 22, 26$14.52Apr 24, 26$14.59Apr 28, 26$14.82Apr 30, 26$14.94May 4, 26$15.20May 6, 26$15.95May 8, 26$17.17May 12, 26$17.17May 14, 26$17.26May 18, 26$16.50May 20, 26$16.59May 22, 26$16.65May 28, 26$16.11Jun 1, 26$15.81Jun 3, 26$15.56Jun 5, 26$15.88Jun 9, 26$16.20Jun 11, 26$16.31Jun 15, 26$16.32Jun 17, 26$15.73Jun 22, 26$15.38Jun 24, 26$15.93Jun 26, 26$16.33Jul 2, 26$16.57
$8.7452-week range$17.39
Loading valuation history…

Fundamentals

Key fundamentals

$18.8B

Market cap

-3.0%

Revenue growth (YoY)

35.1%

Gross margin

$1.9B

Free cash flow (USD)

$13.2B

Net debt

-1.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$11.1BFY 2017$11.9BFY 2018$11.4BFY 2019$11.5BFY 2020$11.9BFY 2021$17.9BFY 2022$16.3BFY 2023$15.4BFY 2024$14.7BFY 2025$14.3B
$11.1B$14.3B

Free cash flow by year

2016 → 2025

FY 2016$1.7BFY 2017$1.8BFY 2018$2.1BFY 2019$1.4BFY 2020$550.6MFY 2021$2.5BFY 2022$2.5BFY 2023$2.3BFY 2024$2.0BFY 2025$1.9B
$1.7B$1.9B

Gross margin by year

2021 → 2025

FY 202131.2%FY 202240.0%FY 202341.7%FY 202438.1%FY 202535.1%
31.2%35.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDebt RefinancingJul 1, 2026Filing
  • Insider sellInsider Sell $810K · 10b5-1 PlanCampbell Paul · See Remarks · $809.8KJun 26, 2026Filing
  • 8-K eventSenior Indenture FiledJun 18, 2026Filing
  • 8-K eventDebt OfferingJun 15, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 15, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventCFO Departure and AppointmentMay 4, 2026Filing

Questions

Frequently asked questions

What is Viatris Inc.'s market cap?

Viatris Inc. (VTRS) has a market capitalization of $18.8B.

What is VTRS's P/E ratio?

A meaningful P/E ratio is not available for VTRS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is VTRS's price-to-book (P/B) ratio?

VTRS trades at 1.28 times book value per share.

Are insiders buying VTRS stock?

SEC Form 4 filings show no open-market insider buys at Viatris Inc. in the last 90 days (1 sell).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

ELAN

Elanco Animal Health Incorporated

$12B

RDY

Dr. Reddy's Laboratories Limited

$11.4B

LNTH

Lantheus Holdings, Inc.

$6.5B

INDV

Indivior Pharmaceuticals Inc

$4.5B

AMRX

Amneal Pharmaceuticals, Inc.

$4.2B

SUPN

Supernus Pharmaceuticals, Inc.

$2.7B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.